Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
TRYT ¥55.2 billion IPO
The shares are listed on the Tokyo Stock Exchange
Johnson & Johnson splits off Kenvue
This is the largest split-off transaction ever done
AN2 Therapeutics $70 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Shockwave Medical $750 million convertible senior notes offering
The 1% convertible notes are due 2028
Cano Health amendment and covenant waiver for side-car credit facility
We advised Rubicon Founders in connection with the transaction
SSI Strategy acquisition of NDA Group
We advised SSI Strategy on the acquisition
Gracell Biotechnologies PIPE of ordinary shares and warrants
The company’s ADSs are listed on Nasdaq
Recursion Pharmaceuticals $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
NGM Biopharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market